Handbook CABOMETYX. Side effect management of CABOMETYX and TKI
Detail Aid. Information about METEOR and CABOSUN trial and how to use CABOMETYX
Reprint – Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial «T Choueiri et al – The Lancet Oncology
Reprint – Cabozantinib versus sunitinib as initial therapy(CABOSUN) T Choueiri et al – The European Journal of Cancer
To patients
Patient guide + a diary – what you need to know as a patient when you start your treatment
Patient start kit – patient guide + some supportive care for PPE/skin tox.
You are about to leave Cabometyx Sweden. This link is provided as a service to our website visitors. It will take you to a website maintained by a third party who is solely responsible for its content. Ipsen does not control, recommend, endorse or accept liability for sites controlled by third parties.
You are about to leave Cabometyx.se. This link is provided as a service to our website visitors. It will take you to another website maintained by Ipsen.